100% de satisfacción garantizada Inmediatamente disponible después del pago Tanto en línea como en PDF No estas atado a nada 4.2 TrustPilot
logo-home
Examen

Nursing - Pharmacology Unit 1 2025

Puntuación
-
Vendido
-
Páginas
13
Grado
A+
Subido en
07-01-2025
Escrito en
2024/2025

Nursing - Pharmacology Unit 1 2025 A patient has a malignant brain tumor, what pharmacokinetic phase may be affected by the presence of a tumor? -ans Distribution phase A patient has an order for a tetracycline antibiotic and has been instructed to avoid taking the medication with foods, beverages, or drugs that contain calcium, iron, or magnesium. The patient takes the antibiotic along with a daily multivitamin, not realizing that the vitamin contains iron. What effect may this have on the tetracycline? -ans Impaired absorption A patient who is in renal failure may have a diminished capacity to excrete medications. The nurse must assess the patient more frequently for what development? -ans Increased risk for drug toxicity. A patient with cirrhosis of the liver exhibits decreased metabolic activity: This will require what possible changes? -ans Reduction in the dosage of the drugs. More frequent monitoring for adverse drug effects.

Mostrar más Leer menos
Institución
Grado









Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Escuela, estudio y materia

Institución
Estudio
Grado

Información del documento

Subido en
7 de enero de 2025
Número de páginas
13
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas

Temas

Vista previa del contenido

Nursing - Pharmacology Unit 1 2025

A patient has a malignant brain tumor, what pharmacokinetic phase may be affected by the presence of a
tumor? -ans Distribution phase



A patient has an order for a tetracycline antibiotic and has been instructed to avoid taking the medication with
foods, beverages, or drugs that contain calcium, iron, or magnesium. The patient takes the antibiotic along with
a daily multivitamin, not realizing that the vitamin contains iron. What effect may this have on the tetracycline?
-ans Impaired absorption



A patient who is in renal failure may have a diminished capacity to excrete medications. The nurse must assess
the patient more frequently for what development? -ans Increased risk for drug toxicity.



A patient with cirrhosis of the liver exhibits decreased metabolic activity: This will require what possible
changes? -ans Reduction in the dosage of the drugs. More frequent monitoring for adverse drug effects.



Absoprtion -ans process involving the movement of a substance from its site of administration, across body
membranes, to circulating fluids.



ac -ans before meals



Active Transport of drugs -ans movement of a chemical against a concentration or electrochemical gradient



ad lib -ans as desired/as directed



Adrenergic Antagonist -ans Blocks physiological reactions to stress



affinity -ans attraction



After a drug is administered, it is called -ans a medication

, agonist -ans a drug that produces the same type of response as the endogenous substance



allergic reaction -ans an acquired hyperresponse of body defenses to a foreign substance (allergen)



AM -ans morning



Anaphylaxis -ans severe type of allergic reaction that involves the massive systemic release of histamine and
other chemical mediators of inflammation that can lead to life threatening shock.



apothecary system -ans older system of measurement (minims, fluid drams, ounces, grains)



Barriers that prevent medications from entering -ans blood-brain barrier, fetal-placental barrier.



bid -ans twice a day



Bioavailability -ans the physiological ability of the drug to reach its target cells and produce its effects.



Biologics -ans agents naturally produced in animal cells, microorganisms, or the body.



Biologics Control Act (1902) -ans Standardizes the quality of serums and other blood-relation products



Black Box Warnings -ans One of the primary alerts for identifying extreme adverse drug reactions discovered
during and after the review process.



Blocks Hormonal Activity -ans Angiotensin-converting enzyme inhibitor
$10.99
Accede al documento completo:

100% de satisfacción garantizada
Inmediatamente disponible después del pago
Tanto en línea como en PDF
No estas atado a nada

Conoce al vendedor
Seller avatar
trizahmanene

Conoce al vendedor

Seller avatar
trizahmanene Chamberlain College Nursing
Seguir Necesitas iniciar sesión para seguir a otros usuarios o asignaturas
Vendido
0
Miembro desde
11 meses
Número de seguidores
0
Documentos
490
Última venta
-

0.0

0 reseñas

5
0
4
0
3
0
2
0
1
0

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes